Some studies reported that MARCH1 was overexpressed in ovarian and colorectal cancers, and knockdown of MARCH1 could inhibit the progression and development of cancer (Meng et al., 2016; Wang et al., 2021). The gene discussed is MARCHF1; the disease is cancer.